Form 4: Spruce Biosciences Executive Receives Stock Grant
Insider Transaction (Form 4)
Adrian W Quartel, Chief Medical Officer of Spruce Biosciences, Inc., received 13,000 shares of common stock on July 27, 2026.
Summary
- Grant/award: acquired 13,000 Restricted Stock Units on July 27, 2026; holds 13,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Adrian W Quartel — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Grant/award | Restricted Stock Units | 13,000 | — | — | 13,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Grant/award (13,000 shares) |
Keywords
insider transaction, Form 4, SPRB, SPRUCE BIOSCIENCES, INC., neutral, Adrian W Quartel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.